您的位置: 首页 > 农业专利 > 详情页

ISOLATED T CELL RECEPTORS AND METHODS OF USE THEREFOR
专利权人:
University of Virginia Patent Foundation
发明人:
Angela Zarling,Victor H. Engelhard,Kara L. Cummings,Rebecca C. Obeng
申请号:
US15303677
公开号:
US20170029484A1
申请日:
2015.04.15
申请国别(地区):
US
年份:
2017
代理人:
摘要:
Provided are isolated TCRs, TCR-like molecules, and portions thereof that bind to phosphopeptide-HLA-A2 complexes. The isolated TCRs, TCR-like molecules, or portions are optionally soluble TCRs, TCR-like molecules, or portions. Also provided are isolated nucleic acids encoding the disclosed TCRs, TCR-like molecules, or portions; host cells that contain the disclosed TCRs, TCR-like molecules, or portions; pharmaceutical compositions that include the disclosed TCRs, TCR-like molecules, portions, nucleic acids, and/or T cells; kits; and methods of using the same.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充